Sinopharm Group and Merck & Co., Inc. Sign Statement of Mutual Intent

WHITEHOUSE STATION, N.J. & BEIJING, China--(BUSINESS WIRE)--Merck, known outside the U.S. and Canada as MSD, and Sinopharm (China National Pharmaceutical Group Corporation) today announced the signing of a statement of mutual intent. Under the statement, Sinopharm and Merck will cooperate on HPV vaccine and other mutually-selected vaccine products in China, and will also discuss the potential for promoting and marketing Merck’s pharmaceutical products in China.

Back to news